Latest News and Press Releases

La publication du JACC-Heart Failure souligne la haute qualité de l'expansion cellulaire, la bonne tolérance, le risque procédural gérable et les signes précoces encourageants d'effets fonctionnels. ...

JACC-Heart Failure publication highlights high-quality cell expansion, good tolerability, manageable procedural risk and encouraging early signals of functional effects. Mulhouse, France – [DATE] –...

CytoSorbents submits DrugSorb-ATR Medical Device License Application to Health Canada following MDSAP Certification. Expects regulatory decision in 2025

MIAMI, April 09, 2024 (GLOBE NEWSWIRE) -- UMeWorld Limited (OTC: UMEWF) is excited to announce that the company has secured an exclusive license to use proprietary enzymatic technologies to...

Powerful Medical Secures €7.5M in Funding from European Innovation Council to Revolutionize Heart Attack Diagnostics with AI

Riverdale, Dec. 06, 2023 (GLOBE NEWSWIRE) -- A study published earlier this year found that the risk of death from a heart attack could potentially double when both temperatures and ambient levels...

Dublin, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The "Thrombosis And Hemostasis Biomarkers Market Size, Share & Trends Analysis Report By Product (Analyzers, Reagents & Consumables), By Test...

PMcardio's Queen of Hearts is the first certified solution to outperform doctors in heart attack detection from the ECG using artificial intelligence.

Wilmington, Delaware, United States, March 08, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – As per a TMR study, the Inotropic Agents Market was valued at US$ 1.9 Bn in 2022 and is...

LATHAM, N.Y., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Mesuron announced today that it has entered into a know-how collaboration agreement and stock purchase agreement with Mayo Clinic to further refine...